191 related articles for article (PubMed ID: 26171932)
1. Long-term subjective cognitive functioning following adjuvant systemic treatment: 7-9 years follow-up of a nationwide cohort of women treated for primary breast cancer.
Amidi A; Christensen S; Mehlsen M; Jensen AB; Pedersen AD; Zachariae R
Br J Cancer; 2015 Sep; 113(5):794-801. PubMed ID: 26171932
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.
Ahles TA; Saykin AJ; Furstenberg CT; Cole B; Mott LA; Skalla K; Whedon MB; Bivens S; Mitchell T; Greenberg ER; Silberfarb PM
J Clin Oncol; 2002 Jan; 20(2):485-93. PubMed ID: 11786578
[TBL] [Abstract][Full Text] [Related]
3. Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study.
van der Willik KD; Koppelmans V; Hauptmann M; Compter A; Ikram MA; Schagen SB
Breast Cancer Res; 2018 Nov; 20(1):135. PubMed ID: 30442190
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
7. Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study.
Janelsins MC; Heckler CE; Peppone LJ; Kamen C; Mustian KM; Mohile SG; Magnuson A; Kleckner IR; Guido JJ; Young KL; Conlin AK; Weiselberg LR; Mitchell JW; Ambrosone CA; Ahles TA; Morrow GR
J Clin Oncol; 2017 Feb; 35(5):506-514. PubMed ID: 28029304
[TBL] [Abstract][Full Text] [Related]
8. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
[TBL] [Abstract][Full Text] [Related]
9. Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.
Schilder CM; Seynaeve C; Linn SC; Boogerd W; Beex LV; Gundy CM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB
Psychooncology; 2012 May; 21(5):479-87. PubMed ID: 21351188
[TBL] [Abstract][Full Text] [Related]
10. Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy.
Joly F; Espié M; Marty M; Héron JF; Henry-Amar M
Br J Cancer; 2000 Sep; 83(5):577-82. PubMed ID: 10944595
[TBL] [Abstract][Full Text] [Related]
11. Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies.
Lee PE; Tierney MC; Wu W; Pritchard KI; Rochon PA
Breast Cancer Res Treat; 2016 Aug; 158(3):407-20. PubMed ID: 27432418
[TBL] [Abstract][Full Text] [Related]
12. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
[TBL] [Abstract][Full Text] [Related]
13. The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients.
Gregorowitsch ML; Ghedri A; Young-Afat DA; Bijlsma R; Baas IO; van Schaik-van de Mheen C; Agterof MJ; Göker E; Ten Bokkel Huinink D; van den Bongard HJGD; Verkooijen HM;
Breast Cancer Res Treat; 2019 Jun; 175(2):429-441. PubMed ID: 30746636
[TBL] [Abstract][Full Text] [Related]
14. The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study.
Tager FA; McKinley PS; Schnabel FR; El-Tamer M; Cheung YK; Fang Y; Golden CR; Frosch ME; Habif U; Mulligan MM; Chen IS; Hershman DL
Breast Cancer Res Treat; 2010 Aug; 123(1):25-34. PubMed ID: 19894112
[TBL] [Abstract][Full Text] [Related]
15. Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight.
Biglia N; Moggio G; Peano E; Sgandurra P; Ponzone R; Nappi RE; Sismondi P
J Sex Med; 2010 May; 7(5):1891-900. PubMed ID: 20233281
[TBL] [Abstract][Full Text] [Related]
16. A retrospective series of long-term survivors of metastatic breast cancer in complete remission.
Amoroso V; Valcamonico F; Simoncini E; Ardighieri L; Grisanti S; Vassalli L; Marpicati P; Lucini L; Ferrari VD; Rangoni G; Marini G
Oncology; 2005; 68(1):48-51. PubMed ID: 15809519
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.
Schilder CM; Eggens PC; Seynaeve C; Linn SC; Boogerd W; Gundy CM; Beex LV; Van Dam FS; Schagen SB
Acta Oncol; 2009; 48(1):76-85. PubMed ID: 18777410
[TBL] [Abstract][Full Text] [Related]
18. Quality of life in long-term breast cancer survivors.
Hsu T; Ennis M; Hood N; Graham M; Goodwin PJ
J Clin Oncol; 2013 Oct; 31(28):3540-8. PubMed ID: 23980087
[TBL] [Abstract][Full Text] [Related]
19. Cognitive deficits in Korean women treated with chemotherapy for breast cancer.
Jung MS; Cimprich B
Cancer Nurs; 2014; 37(3):E31-42. PubMed ID: 23945143
[TBL] [Abstract][Full Text] [Related]
20. Analysis of memory deficits following chemotherapy in breast cancer survivors: evidence from the doors and people test.
Prokasheva S; Faran Y; Cwikel J; Geffen DB
J Psychosoc Oncol; 2011; 29(5):499-514. PubMed ID: 21882931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
